CN101391071B - Traditional Chinese medicine for treating diabetic ocular fundus diseases - Google Patents

Traditional Chinese medicine for treating diabetic ocular fundus diseases Download PDF

Info

Publication number
CN101391071B
CN101391071B CN2007101221143A CN200710122114A CN101391071B CN 101391071 B CN101391071 B CN 101391071B CN 2007101221143 A CN2007101221143 A CN 2007101221143A CN 200710122114 A CN200710122114 A CN 200710122114A CN 101391071 B CN101391071 B CN 101391071B
Authority
CN
China
Prior art keywords
parts
chinese medicine
radix
fine powder
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007101221143A
Other languages
Chinese (zh)
Other versions
CN101391071A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wei Dezong
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2007101221143A priority Critical patent/CN101391071B/en
Publication of CN101391071A publication Critical patent/CN101391071A/en
Application granted granted Critical
Publication of CN101391071B publication Critical patent/CN101391071B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Disclosed is a Chinese traditional medicine for curing diabetes eyeground pathological changes, which belongs to the Chinese traditional medicine for curing diabetes; the medicine has the advantages of fine curative and immediate effect; the medicine is composed of following materials: medlar, chrysanthemum, glossy ganoderma, spores of ganoderma lucidum, motherwort, gamene, angelica, common burreed rhizome, rhizoma zedoariae and sanchi; with functions of reinforcing the vital energy and consolidating the constitution, supplementing qi and nourishing Blood, and promoting blood circulation by removing blood stasis, the medicine has the advantages of treat both symptoms and root cause of disease, obvious effect and immediate effect.

Description

A kind of Chinese medicine for the treatment of diabetic ocular fundus diseases
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of diabetic retinopathy, belong to a kind of treatment diabetes Chinese medicine.
Background technology
The existing Chinese medicine that is intended to treat diabetic ocular fundus diseases, exist some obviously not enough: the one, effect is humbleer, the 2nd, it is slower to take effect, western medicine and medical practitioners is dry and astringent to blurred vision, the eyes that the diabetes-alleviating retinopathy forms in addition, not effective especially means and channel are so that a large amount of diabetic retinopathy patient constantly develops into blind.At above problem, the invention provides a kind of Chinese medicine for the treatment of diabetic ocular fundus diseases, it can solve humble, the slow problem that takes effect of treatment by Chinese herbs effect in the past, and is effective, instant effect, have treating both the principal and secondary aspects of a disease, effect significantly, characteristics rapidly take effect.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of diabetic ocular fundus diseases adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Fructus Lycii 5---10 parts of 22 parts of Flos Chrysanthemis 2---7 portions of Ganodermas 0.9---
Ganoderma spore powder 0.8---10 parts of 10 parts of Herba Leonuris 4---15 portions of Radix Rubiaes 1.5---
Radix Angelicae Sinensis 4---8 parts of 15 parts of rhizoma sparganic 2---7 parts of Rhizoma Curcumae 2---
Radix Notoginseng 2---18 parts
The Chinese medicine of this treatment diabetic ocular fundus diseases is made by following method:
(1) by above-mentioned weight ratio, Fructus Lycii, Flos Chrysanthemi, Herba Leonuri, Radix Rubiae, Radix Angelicae Sinensis, rhizoma sparganic, Rhizoma Curcumae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, Ganoderma is ground into fine powder, mix, stir, as required, can be made into multiple dosage forms such as granule, powder, capsule, tablet with Ganoderma spore powder.
2, a kind of Chinese medicine as claimed in claim 1 is characterized in that: it is the Chinese medicine that is used for the treatment of diabetic ocular fundus diseases.
The present invention is according to the folk tradition prescription, and the mechanism of, hematogenous blockage sticky according to diabetic ophthalmopathy blood, retina generation microangiopathies is taked the theory of traditional Chinese medical science the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling, develops meticulously; Ganoderma and spore powder alleviating distention in middle-JIAO QI invigorating, tonification the five internal organs in the side, Radix Angelicae Sinensis blood-enriching and blood-promoting circulation, Radix Rubiae, Herba Leonuri, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling; Rhizoma sparganic, Rhizoma Curcumae promoting the circulation of blood removing blood stasis with potent drugs promote to absorb, to strengthen that clearing up of spot oozed out on the optical fundus; The Flos Chrysanthemi wind-dispelling heat-dissipating, detoxifcation makes eye bright, the Fructus Lycii nourishing the liver and kidney, replenishing vital essence to improve eyesight, to alleviate because of the deficiency of both the liver and kidney blurred vision is not clear, two are dry and astringent.Pass through all medicines of full side and depend on each other for existence, maximize favourable factors and minimize unfavourable ones, bring out the best in each other, play benefiting QI and nourishing blood altogether, the effect of blood circulation promoting and blood stasis dispelling, effective, instant effect, have treating both the principal and secondary aspects of a disease, effect significantly, characteristics rapidly take effect.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, gets following prescription (weight is unit by gram)
Fructus Lycii 50 gram Flos Chrysanthemis 20 kairine sesames 10 grams
Ganoderma spore powder 8 gram Herba Leonuris 40 gram Radix Rubiaes 15 grams
Radix Angelicae Sinensis 40 gram rhizoma sparganic 20 gram Rhizoma Curcumae 22 grams
Radix Notoginseng 20 grams
Weight is extracted Fructus Lycii, Flos Chrysanthemi, Herba Leonuri, Radix Rubiae, Radix Angelicae Sinensis, rhizoma sparganic, Rhizoma Curcumae with conventional water extraction process in accordance with regulations, makes extractum fine powder 82.8 grams; Radix Notoginseng is ground into fine powder, Ganoderma is ground into fine powder, mix with Ganoderma spore powder and extractum fine powder, stir, make fine particle, the capsule of packing into No. 0 is made 483 of Chinese medicinal capsules altogether.Every capsule includes Chinese medicine fine powder and extract 0.25 gram.
2, get following prescription (weight is unit by gram)
Fructus Lycii 150 gram Flos Chrysanthemis 30 kairine sesames 50 grams
Ganoderma spore powder 45 gram Herba Leonuris 100 gram Radix Rubiaes 55 grams
Radix Angelicae Sinensis 90 gram rhizoma sparganic 50 gram Rhizoma Curcumae 50 grams
Radix Notoginseng 120 grams
Make 1700 of Chinese medicinal capsules by above-mentioned same method, every capsule includes Chinese medicine fine powder and extract 0.25 gram.
3, get following prescription (weight is unit by gram)
Fructus Lycii 220 gram Flos Chrysanthemis 70 kairine sesames 100 grams
Ganoderma spore powder 90 gram Herba Leonuris 140 gram Radix Rubiaes 100 grams
Radix Angelicae Sinensis 150 gram rhizoma sparganic 70 gram Rhizoma Curcumae 70 grams
Radix Notoginseng 150 grams
Make 2672 of Chinese medicinal capsules by above-mentioned same method, every capsule includes Chinese medicine fine powder and extract 0.25 gram.
4, get following prescription (by weight)
1.2 parts of 3 portions of Ganodermas of 7 parts of Flos Chrysanthemis of Fructus Lycii
2 parts in 5 portions of Radix Rubiaes of 1.2 parts of Herba Leonuris of Ganoderma spore powder
3 parts of 3 parts of Rhizoma Curcumae of 5 parts of rhizoma sparganic of Radix Angelicae Sinensis
4 parts of Radix Notoginseng
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.25 gram.
5, get following prescription (by weight)
9 parts of 7 portions of Ganodermas of 18 parts of Flos Chrysanthemis of Fructus Lycii
8 parts in 15 portions of Radix Rubiaes of 9 parts of Herba Leonuris of Ganoderma spore powder
6 parts of 6 parts of Rhizoma Curcumae of 15 parts of rhizoma sparganic of Radix Angelicae Sinensis
15 parts of Radix Notoginseng
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.25 gram.
Clinical data:
The present invention is example with the diabetic ocular fundus diseases, through 42 routine clinical observation experiments.Select the standard of diabetic retinopathy: have a dizzy spell, gum is too much; Binocular dryness, eye socket pain; Visual deterioration, blurred vision; That retina occurs is hemorrhage, edema, ooze out.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 23 examples, women's 19 examples do not have other serious disease, and the age is 47---79 years old, 61.9 years old mean age.
Efficacy determination:
1, produce effects: gum is normal, eyes Clear and Bright; Binocular dryness disappears, and eyes are comfortable; Blurred vision is alleviated, and vision improves more than 0.1; The white macula that the optical fundus occurs, macula lutea, blood stain quantity reduce, and area dwindles.
2, effective: the dry and astringent disappearance of eyes, blurred vision is alleviated.
3, invalid: the symptom no change.
During clinical experiment, withdraw other medicines and health nutrient.Take Chinese medicinal capsule of the present invention, observing 90 days is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.25 gram, ante cibum warm water delivery service, symptom promptly has alleviation after 30 days, take 90 days after, symptom has clear improvement.42 philtrums of clinical experiment, produce effects 19 people, effective 20 people, invalid 3 people, total effective rate 92.8%.

Claims (1)

1. Chinese medicine for the treatment of diabetic ocular fundus diseases, it is characterized in that: it is that the component of following column weight amount proportioning is made: Fructus Lycii 5---22 parts, Flos Chrysanthemi 2---7 parts, Ganoderma 0.9---10 parts, Ganoderma spore powder 0.8---10 parts, Herba Leonuri 4---15 parts, Radix Rubiae 1.5---10 parts, Radix Angelicae Sinensis 4---15 parts, rhizoma sparganic 2---7 parts, Rhizoma Curcumae 2---8 parts, Radix Notoginseng 2---18 parts;
The Chinese medicine of this treatment diabetic ocular fundus diseases is made by following method:
(1), with Fructus Lycii, Flos Chrysanthemi, Herba Leonuri, Radix Rubiae, Radix Angelicae Sinensis, rhizoma sparganic, Rhizoma Curcumae, extract, makes the extractum fine powder through conventional water extraction process by above-mentioned weight ratio;
(2) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, Ganoderma is ground into fine powder, mix, stir with Ganoderma spore powder and extractum fine powder; As required, make granule, powder, capsule, Tabules.
CN2007101221143A 2007-09-21 2007-09-21 Traditional Chinese medicine for treating diabetic ocular fundus diseases Expired - Fee Related CN101391071B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007101221143A CN101391071B (en) 2007-09-21 2007-09-21 Traditional Chinese medicine for treating diabetic ocular fundus diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007101221143A CN101391071B (en) 2007-09-21 2007-09-21 Traditional Chinese medicine for treating diabetic ocular fundus diseases

Publications (2)

Publication Number Publication Date
CN101391071A CN101391071A (en) 2009-03-25
CN101391071B true CN101391071B (en) 2010-12-01

Family

ID=40491712

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007101221143A Expired - Fee Related CN101391071B (en) 2007-09-21 2007-09-21 Traditional Chinese medicine for treating diabetic ocular fundus diseases

Country Status (1)

Country Link
CN (1) CN101391071B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103071089B (en) * 2013-01-18 2014-03-12 管丽芳 Traditional Chinese medicine powder for treating epidemic keratoconjunctivitis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1365816A (en) * 2001-01-16 2002-08-28 袁修成 Health-care medicine containing ganoderic oligose for preventing and treating cardiovascular disease and its preparing process
CN1846764A (en) * 2005-04-15 2006-10-18 张伟 Health medicinal wine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1365816A (en) * 2001-01-16 2002-08-28 袁修成 Health-care medicine containing ganoderic oligose for preventing and treating cardiovascular disease and its preparing process
CN1846764A (en) * 2005-04-15 2006-10-18 张伟 Health medicinal wine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张娟.止血愈消汤治疗糖尿病视网膜病变眼底出血36例.《浙江中医杂志》.2006,第41卷(第8期), *
谷启全.化痰祛瘀法治疗糖尿病眼底病变疗效观察.《山东中医杂志》.2006,第25卷(第4期), *

Also Published As

Publication number Publication date
CN101391071A (en) 2009-03-25

Similar Documents

Publication Publication Date Title
CN101391071B (en) Traditional Chinese medicine for treating diabetic ocular fundus diseases
CN102379967A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN101884693B (en) Traditional Chinese medicine for treating diabetic eye diseases
CN101843837B (en) Chinese medicament for treating diabetic oculopathy
CN101843786A (en) Chinese medicament for treating diabetic eyeground pathological changes
CN101843836B (en) Chinese medicament for treating diabetic oculopathy
CN101966258A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN101843834B (en) Chinese medicament for treating diabetic eyeground pathological changes
CN102018757A (en) Traditional Chinese medicine for treating eyeground pathological changes caused by diabetes
CN101843772A (en) Chinese medicament for treating diabetic oculopathy
CN101843857B (en) Chinese medicament for treating diabetic eyeground pathological changes
CN101972343A (en) Traditional Chinese medicine for treating diabetic oculopathy
CN101940659A (en) Traditional Chinese medicine for treating diabetic eye disease
CN101843788A (en) Chinese medicament for treating diabetic oculopathy
CN101953939A (en) Chinese medicament for treating diabetic eye diseases
CN101843770A (en) Chinese medicament for treating diabetic oculopathy
CN101897809A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN101843727A (en) Chinese medicament for treating diabetic oculopathy
CN101953938A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN102114121A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN102389495A (en) Traditional Chinese medicine for curing diabetic retinopathy
CN101843774A (en) Chinese medicament for treating diabetic eyeground pathological changes
CN102139054A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN101983656A (en) Traditional Chinese medicine for treating diabetic eye disease
CN102091223A (en) Traditional Chinese medicine for treating diabetic eye diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: WEI DEZONG

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20141218

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 541105 GUILIN, GUANGXI ZHUANG AUTONOMOUS REGION

TR01 Transfer of patent right

Effective date of registration: 20141218

Address after: 541105, room 2, unit 8, 1 Xing Xing Road, 202 Town, Lingui County, the Guangxi Zhuang Autonomous Region, Lingui

Patentee after: Wei Dezong

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 Building 10 room 602

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101201

Termination date: 20170921